Curative treatment of APL is accomplished with arsenic compounds that cause poly-SUMOylation of PML-RARα, which facilitates degradation of the oncoprotein and restoration of PML bodies [52,53,54]. The gene discussed is PML; the disease is acute promyelocytic leukemia.